Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M962Revenue (TTM) $M882Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $1.8Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M27.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BRLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BRLIMario Gabelli 2015-09-30 Sold Out -0.01%$34.61 - $46.68
($42)
$ 34.61-18%Sold Out0
BRLIJoel Greenblatt 2015-06-30 Sold Out $32.55 - $41.93
($35.84)
$ 34.61-3%Sold Out0
BRLIMario Gabelli 2015-06-30 Reduce$32.55 - $41.93
($35.84)
$ 34.61-3%Reduce -3.69%62,600
BRLIJoel Greenblatt 2015-03-31 Add$31.31 - $36.51
($33.83)
$ 34.612%Add 16.52%13,925
BRLIMario Gabelli 2015-03-31 Add$31.31 - $36.51
($33.83)
$ 34.612%Add 10.17%65,000
BRLIJoel Greenblatt 2014-12-31 Buy $27.14 - $32.37
($28.93)
$ 34.6120%New holding11,951
BRLIJoel Greenblatt 2014-03-31 Sold Out -0.02%$24.39 - $28.26
($26.12)
$ 34.6133%Sold Out0
BRLIJoel Greenblatt 2013-12-31 Reduce-0.02%$25.17 - $37.73
($30.93)
$ 34.6112%Reduce -35.54%30,507
BRLIJoel Greenblatt 2013-06-30 Reduce-0.06%$23.58 - $31.9
($27.55)
$ 34.6126%Reduce -46.02%56,271
BRLIJoel Greenblatt 2013-03-31 Add0.03%$24.91 - $31.05
($27.69)
$ 34.6125%Add 21.81%104,240
BRLIJoel Greenblatt 2012-12-31 Add0.05%$24.68 - $32.42
($28.64)
$ 34.6121%Add 48.67%85,579
BRLIJoel Greenblatt 2012-03-31 Buy 0.12%$16.27 - $23.76
($18.82)
$ 34.6184%New holding57,406
BRLIMario Gabelli 2011-06-30 Add$20.57 - $25.24
($23.29)
$ 34.6149%Add 27.78%36,800
BRLIFirst Eagle Investment 2010-12-31 Buy $20.24 - $22.79
($21.43)
$ 34.6162%New holding10,000
BRLIMario Gabelli 2010-09-30 Buy $18.51 - $22.04
($20.47)
$ 34.6169%New holding36,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BRLI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BRLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DUBINETT HOWARDExecutive VP, COO 2013-09-13Sell20,000$29.417.72view
SINGER SAMSVP, CFO and CAO 2013-06-27Sell4,000$28.9519.55view
SINGER SAMSVP, CFO & CAO 2013-06-26Sell6,000$28.521.44view
SINGER SAMSr. VP, Sec'y, Treasurer, CFO 2013-01-10Sell2,000$28.9919.39view
DUBINETT HOWARDExecutive VP, COO 2012-12-18Sell10,000$29.6616.69view
ELIAS HARRYDirector 2012-03-07Sell2,000$22.2555.55view
GRODMAN MARCPresident, CEO, 10% Owner 2011-12-13Buy5,000$14.68135.76view
ELIAS HARRYDirector 2011-12-13Buy2,000$14.52138.36view
DUBINETT HOWARDExecutive VP, COO 2011-12-12Buy10,000$14.24143.05view
SINGER SAMSr. VP, Sec'y, Treasurer, CFO 2011-12-12Buy2,000$14.31141.86view

Quarterly/Annual Reports about BRLI:

    News about BRLI:

    Articles On GuruFocus.com
    Small cap high short interest (Predictability = 5), Part 1 Oct 16 2014 
    Why I Like These Two Health Care Stocks Aug 29 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    DaVita Seems to be a High-Growth Company Aug 20 2014 
    Small-Cap Consensus Picks By The Investing Gurus Jul 25 2014 
    4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of Apr 16 2014 
    Medical Diagnostic Labs Facing Medicare Headwinds Mar 25 2014 
    Historical Short Interest Of Stocks – New Feature Announcement Jan 17 2014 
    New Feature Announcement: Stocks With The Highest Short Interest Dec 12 2013 
    5 Ways to See Why Bio-Reference Labs Is a Solid Stock Mar 29 2013 

    More From Other Websites
    Why Britain's NHS Is Great, Despite Its Dire Financial Situation Jul 30 2016
    Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug Jun 30 2016
    OPKO Health Refinances Bio-Reference Laboratories Credit Facility Nov 06 2015
    Opko Health Has Crashed 55% In Three Months; Time To Buy? Sep 28 2015
    Innospec Set to Join the S&P SmallCap 600 Aug 20 2015
    BIO REFERENCE LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 20 2015
    BIO REFERENCE LABORATORIES INC Files SEC form 8-K, Other Events Aug 10 2015
    Bio-Reference Laboratories posts 2Q profit Jun 08 2015
    T-Mobile and Lands' End are big market movers Jun 04 2015
    Why Opko’s Acquisition Will Transform Its Future Growth Jun 04 2015
    Bio-Reference Laboratories posts 1Q profit Mar 05 2015
    Bio-Reference Laboratories posts 4Q profit Dec 18 2014
    Genomics startup NextCode stakes claim in pediatric disease market Dec 10 2014

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)